Avalo Therapeutics Inc (AVTX) — Cash Flow Quality Index
Avalo Therapeutics Inc (AVTX) has a Cash Flow Quality Index of -0.50x as of September 2024. Operating cash flow of $-11.53 Million is below net income of $23.04 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AVTX cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avalo Therapeutics Inc Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Avalo Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AVTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Avalo Therapeutics Inc (2017–2017)
Year-by-year earnings quality comparison for Avalo Therapeutics Inc. For live market cap and the full company financial profile, see market value of Avalo Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | 1.05x | $12.52 Million | $11.87 Million | — |